GCO Stock Analysis: Genesco | NYSE
Apparel Retail | NYSE, USA | Market Cap: 400m USD | 12M Return: 27.3% | US3715321028 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.87M
EPS Trend: 53.3%
Qual. Beats: 2
Rev. Trend: 90.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Genesco Inc. is a multi-brand footwear retailer and wholesaler operating through four segments: Journeys Group (youth-focused chains Journeys, Journeys Kidz, and Little Burgundy), Schuh Group (UK-based casual and athletic footwear retailer), Johnston & Murphy Group (mens footwear retail, e-commerce, and wholesale), and Genesco Brands Group (licensed footwear under Levis, Dockers, and other brands). The company distributes through retail stores in the U.S., Puerto Rico, Canada, the U.K., and Ireland, alongside a portfolio of e-commerce sites.
Operating in the Consumer Discretionary sector, Genesco is exposed to apparel retail cyclicality, with demand sensitive to discretionary consumer spending and trends in youth and casual footwear. Its multi-brand, multi-channel model combines owned retail, licensed brand wholesale, and direct-to-consumer e-commerce, providing diversification across customer demographics and geographies.
- Journeys teen traffic declines as mall foot traffic softens
- Schuh UK sales pressured by weak British consumer spending
- Footwear tariffs and freight costs pressure gross margins
| Net Income: 41.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 7.69 > 1.0 |
| NWC/Revenue: 10.26% < 20% (prev 11.41%; Δ -1.15% < -1%) |
| CFO/TA 0.09 > 3% & CFO 134.1m > Net Income 41.6m |
| Net Debt (526.8m) to EBITDA (88.3m): 5.96 < 3 |
| Current Ratio: 1.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.5m) vs 12m ago 0.86% < -2% |
| Gross Margin: 46.65% > 18% (prev 46.82%; Δ -0.17% > 0.5%) |
| Asset Turnover: 168.0% > 50% (prev 169.6%; Δ -1.62% > 0%) |
| Interest Coverage Ratio: 12.07 > 6 (EBIT TTM 35.4m / Interest Expense TTM 2.94m) |
| A: 0.17 (Total Current Assets 676.3m - Total Current Liabilities 426.8m) / Total Assets 1.50b |
| B: 0.17 (Retained Earnings 251.9m / Total Assets 1.50b) |
| C: 0.02 (EBIT TTM 35.4m / Avg Total Assets 1.45b) |
| D: 0.59 (Book Value of Equity 557.0m / Total Liabilities 947.3m) |
| Altman-Z'' = 2.42 = A |
| DSRI: 0.71 (Receivables 39.7m/54.3m, Revenue 2.43b/2.36b) |
| GMI: 1.00 (GM 46.82% / 46.65%) |
| AQI: 1.72 (AQ_t 0.04 / AQ_t-1 0.02) |
| SGI: 1.03 (Revenue 2.43b / 2.36b) |
| TATA: -0.06 (NI 41.6m - CFO 134.1m) / TA 1.50b) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of October 31, 2026, the stock is trading at USD 37.65 with a total of 143,004 shares traded. Over the past week, the price has changed by +0.99%, over one month by +9.45%, over three months by -3.38% and over the past year by +27.27%.
Current recommended Stop Loss: 35.30 (which is 6.2% or 1.9 ATR below the current price).
Genesco has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold GCO.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 39.7 | 5.4% |
P/E Trailing = 9.5829
P/E Forward = 14.6199
P/S = 0.1645
P/B = 0.6825
P/EG = 0.6838
Revenue TTM = 2.43b USD
EBIT TTM = 35.4m USD
EBITDA TTM = 88.3m USD
Long Term Debt = 15.8m USD (from longTermDebt, last quarter)
Short Term Debt = 108.7m USD (from shortTermDebt, last quarter)
Debt = 583.9m USD (from shortLongTermDebtTotal, last quarter) (leases 568.1m already included)
Net Debt = 526.8m USD (calculated: Debt 583.9m - CCE 57.1m)
Enterprise Value = 927.0m USD (400.2m + Debt 583.9m - CCE 57.1m)
Interest Coverage Ratio = 12.07 (Ebit TTM 35.4m / Interest Expense TTM 2.94m)
EV/FCF = 6.82x (Enterprise Value 927.0m / FCF TTM 135.9m)
FCF Yield = 14.66% (FCF TTM 135.9m / Enterprise Value 927.0m)
FCF Margin = 5.59% (FCF TTM 135.9m / Revenue TTM 2.43b)
Net Margin = 1.71% (Net Income TTM 41.6m / Revenue TTM 2.43b)
Gross Margin = 46.65% ((Revenue TTM 2.43b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 47.24% (prev 47.00%)
Tobins Q-Ratio = 0.62 (Enterprise Value 927.0m / Total Assets 1.50b)
Interest Expense / Debt = 0.50% (Interest Expense 2.94m / Debt 583.9m)
Taxrate = 9.17% (4.20m / 45.8m)
NOPAT = 32.2m (EBIT 35.4m * (1 - 9.17%))
Current Ratio = 1.58 (Total Current Assets 676.3m / Total Current Liabilities 426.8m)
Debt / Equity = 1.05 (Debt 583.9m / totalStockholderEquity, last quarter 557.0m)
Debt / EBITDA = 5.96 (Net Debt 526.8m / EBITDA 88.3m)
Debt / FCF = 3.88 (Net Debt 526.8m / FCF TTM 135.9m)
Total Stockholder Equity = 547.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.87% (Net Income 41.6m / Total Assets 1.50b)
RoE = 7.60% (Net Income TTM 41.6m / Total Stockholder Equity 547.6m)
RoCE = 6.29% (EBIT 35.4m / Capital Employed (Equity 547.6m + L.T.Debt 15.8m))
RoIC = 2.85% (NOPAT 32.2m / Invested Capital 1.13b)
WACC = 5.06% (E(400.2m)/V(984.1m) * Re(11.78%) + D(583.9m)/V(984.1m) * Rd(0.50%) * (1-Tc(0.09)))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -72.47 | Cagr: -1.84%
[DCF] Terminal Value 77.97% ; FCFF base≈89.0m ; Y1≈102.1m ; Y5≈150.2m
[DCF] Fair Price = 160.3 (EV 2.26b - Net Debt 526.8m = Equity 1.73b / Shares 10.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 53.29 | EPS CAGR: 51.61% | SUE: 3.00 | # QB: 2
Revenue Correlation: 90.84 | Revenue CAGR: 2.38% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.93 | Chg30d=-22.22% | Revisions=-57% | Analysts=4
EPS current Year (2027-01-31): EPS=2.36 | Chg30d=+5.00% | Revisions=+50% | GrowthEPS=+62.9% | GrowthRev=-2.1%
EPS next Year (2028-01-31): EPS=2.95 | Chg30d=+3.06% | Revisions=+50% | GrowthEPS=+24.9% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +15% (up=6, down=4)